Search for: "FOREST PHARMACEUTICALS, INC.," Results 161 - 177 of 177
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Nov 2014, 8:01 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 599 (1993) (Rehnquist, C.J., concurring in part and dissenting in part) (‘‘the various briefs filed in this case … deal with definitions of scientific knowledge, scientific method, scientific validity, and peer review—in short, matters far afield from the expertise of judges’’); Marconi Wireless Telegraph Co. of America v. [read post]
26 Oct 2009, 6:25 am
Medico (Filewrapper) BPAI finds claim indefinite and not directed to patentable subject under Bilski: Ex parte Hemmat (GRAY On Claims) District Court N D Illinois: KSR obviousness does not require prior art from the same field: Se-Kure Controls, Inc v Diam USA, Inc (Chicago Intellectual Property Law Blog) District Court E D Texas finds plaintiff has standing; agreement transfers ownership and simultaneously a conditional purchase by transferor from transferee: Balsam Coffee… [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog)   Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris: (c5-online.com), 2… [read post]
23 Jan 2010, 6:53 pm by admin
The first agreement was with Hologic Inc., a Bedford, Mass. [read post]
29 Sep 2010, 7:48 am by Steve Hall
The only company in the United States that makes the drug, Hospira Inc. of Lake Forest, Ill., says it has run out and that the next batch won't be available until 2011. [read post]
2 Feb 2011, 10:32 am by Steve Hall
Steve Beshear and Justice and Public Safety Cabinet spokeswoman Jennifer Brislin said no decisions have been made since Hospira Inc., a Lake Forest, Ill., company, announced Jan. 21 that it would quit making sodium thiopental. [read post]
31 Jan 2008, 12:22 am
Pharmaceuticals for GlaxoSmithKline Christopher Viehbacher From Senate Finance Ranking Member Chuck Grassley (PDF 25.5 KB)Letter Requests Information About the Receipt of a Manuscript Before Publication in the New England Journal of Medicine01/30/2008 Letter to Secretary of Agriculture Ed Schafer From Sen. [read post]
21 May 2010, 8:58 am by Eric Guttag
 See Not Losing the Forest for the Trees: Newman Concurs in Ariad where Newman’s concurring opinion concisely captured the essence (and not simply the form) of the “written description” requirement, and why the patent in Ariad Pharmaceuticals v. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro (Escitalopram)… [read post]
6 Oct 2011, 2:53 pm by Lovechilde
Waste Control Specialists Inc., a subsidiary of Simmon’s Contran Corp., had been operating a hazardous waste dump in [read post]
23 Jan 2023, 4:15 am by Allan Blutstein
Aug. 5, 2022) -- affirming district court’s decision that Exemption 4 protected portions of pharmaceutical company's successful application for accelerated approval of a drug. [read post]